Apolipoprotein B Production Reduces Lipotoxic Cardiomyopathy
Open Access
- 1 February 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (6) , 4204-4211
- https://doi.org/10.1074/jbc.m311995200
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Overexpression of Apolipoprotein B in the Heart Impedes Cardiac Triglyceride Accumulation and Development of Cardiac Dysfunction in Diabetic MiceJournal of Biological Chemistry, 2002
- Complexity in the Secretory Pathway: The Assembly and Secretion of Apolipoprotein B-containing LipoproteinsJournal of Biological Chemistry, 2002
- Mechanisms of LipoapoptosisTrends in Cardiovascular Medicine, 2002
- Very Low Density Lipoprotein (VLDL) Receptor-deficient Mice Have Reduced Lipoprotein Lipase ActivityJournal of Biological Chemistry, 2002
- Post-transcriptional Stimulation of the Assembly and Secretion of Triglyceride-rich Apolipoprotein B Lipoproteins in a Mouse with Selective Deficiency of Brown Adipose Tissue, Obesity, and Insulin ResistancePublished by Elsevier ,2001
- Lipoprotein Secretion and Triglyceride Stores in the HeartPublished by Elsevier ,2001
- A novel mouse model of lipotoxic cardiomyopathyJournal of Clinical Investigation, 2001
- Apo B100-containing lipoproteins are secreted by the heart.Journal of Clinical Investigation, 1998
- Associations Between Diet and the Hyperapobetalipoproteinemia Phenotype Expression in Children and Young AdultsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989